First topical pharmacologic therapy to enter clinical trials for ‘double chin’
Topokine Therapeutics has initiated dosing in a Phase 2, randomised controlled clinical trial of XAF5 Gel for reduction of excess...
Read MoreNov 27, 2013 | 0 |
Topokine Therapeutics has initiated dosing in a Phase 2, randomised controlled clinical trial of XAF5 Gel for reduction of excess...
Read More